Meeting
2018 Gastrointestinal Cancers Symposium
An analysis of the efficacy and safety of direct oral anticoagulants (DOACs) in gastrointestinal cancer-associated venous thromboembolism (GI-CAVTE).
Authors
Alejandro Recio Boiles
University of Arizona Cancer Center, Tucson, AZ
Alejandro Recio Boiles , Hani M. Babiker , Aaron James Scott , Steve Malangone , Ali McBride , Emad Elquza
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 505)
DOI
10.1200/JCO.2018.36.4_suppl.505
Abstract #
505
Poster Bd #
P5
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Evaluation of direct oral anticoagulant use for cancer-associated venous thromboembolism (VTE) in lung cancer.
First Author: Leila Rostamnjad
Poster
2016 Gastrointestinal Cancers Symposium
Review of efficacy and safety of the new oral anticoagulants (NOACS) in the treatment of venous thromboembolism in gastrointestinal (GI) oncology patients.
First Author: Hitendra Patel
Poster
2021 Genitourinary Cancers Symposium
A retrospective real-world major bleeding (MB) comparison of direct oral anticoagulants (DOAC) and low molecular weight heparin (LMWH) in genitourinary cancer-associated venous thromboembolism (GU-CAVTE) with reported randomized clinical trials (RTC).
First Author: Ulyana Dashkevych
Poster
2019 Gastrointestinal Cancers Symposium
An analysis of the safety and efficacy of rivaroxaban (Riv) and low molecular weight heparin (LMWH) in gastrointestinal cancer-associated venous thromboembolism (GICA-VTE).
First Author: Alejandro Recio Boiles